【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary, 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, December 2012 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, December 2012 9
2.2.1 Roche Revises Offer Price to Acquire Illumina for Up to $8.2 Billion 9
2.2.2 Teva Pharma Completes Public Offering of Notes for $2 Billion 9
2.2.3 HCA Completes Public Offering of Notes Due 2021 for $1 Billion 10
2.2.4 Mylan Prices Private Placement of Notes Due 2023 for $750 Million 10
2.2.5 Mitsubishi Chemical to Acquire Qualicaps from Carlyle Group for $660 Million 10
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, December 2012 11
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, December 2012 12
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 13
3.1 Pharmaceuticals & Healthcare, Global, M&A, December 2012 13
3.1.1 Top M&A Deals in December 2012 14
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, July 2012-December 2012 14
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, December 2012 15
3.2.1 Top Equity Offering Deals in December 2012 16
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, July 2012 – December 2012 16
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, December 2012 17
3.3.1 Top PE/VC Deals in December 2012 18
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, December 2012 19
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, December 2012 20
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, July 2012 – December 2012 21
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, July 2012 – December 2012 22
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2012 23
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2012 23
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, July 2012 – December 2012 24
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), December 2012 25
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, December 2012 25
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), July 2012 – December 2012 26
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, July 2012 – December 2012 27
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), July 2012 – December 2012 28
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), July 2012 – December 2012 29
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2012 30
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2012 30
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), December 2012 31
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, December 2012 32
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, December 2012 32
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, December 2012 33
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), July 2012 – December 2012 34
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), July 2012 – December 2012 35
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), July 2012 – December 2012 36
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), July 2012 – December 2012 37
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 39
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, December 2012 39
6.1.1 Oncology – Deals of the Month 40
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, December 2012 41
6.2.1 Central Nervous System – Deals of the Month 42
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, December 2012 43
6.3.1 Infectious Diseases – Deals of the Month 44
6.4 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, December 2012 45
6.4.1 Metabolic Disorders – Deal of the Month 46
6.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, December 2012 47
6.5.1 Immunology – Deal of the Month 48
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, December 2012 49
6.6.1 Cardiovascular – Deal of the Month 50
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, December 2012 51
6.7.1 Gastrointestinal – Deals of the Month 52
7 Deal Summary by Geography 53
7.1 Pharmaceuticals & Healthcare, North America Deals, December 2012 53
7.1.1 North America – Deals of the Month 54
7.2 Pharmaceuticals & Healthcare, Europe, Deals, December 2012 55
7.2.1 Europe – Deals of the Month 56
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, December 2012 57
7.3.1 Asia-Pacific – Deals of the Month 58
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, December 2012 59
7.4.1 Rest of the World – Deals of the Month 60
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 61
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, July 2012 – December 2012 61
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, July 2012 – December 2012 62
9 Further Information 63
9.1 Methodology 63
9.2 About GlobalData 64
9.3 Contact Us 64
9.4 Disclosure information 64
9.5 Disclaimer 64
【レポート販売概要】
■ タイトル：事業提携・ライセンシング・投資・M&A動向：December 2012（製薬業界）■ 英文：Partnerships, Licensing, Investments and M&A Deals and Trends For December 2012 In Pharmaceuticals
■ 発行日：2013年1月14日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160054
■ 調査対象地域：グローバル
- 超高精細テレビ（UHD TV）の世界市場2015-2019About UHD TVs The global TV market is undergoing a rapid transformation in terms of display resolution. UHD TV is one of the most significant innovation that took place in the market space after FHD TV. The introduction of UHD TVs has influenced the increasing screen size of TVs and large-screen TVs are high in demand. The vendors are increasing their R&D investments to cater to the demand for imp …
- 防弾ヘルメットの世界市場2016-2020About Bulletproof Helmets Bullet proof helmets are used for enhancing safety in defense, military, and homeland security. They are used by wearers for protection from potentially hazardous elements that range from air-borne flying particles, ballistic threats, and fragments. The global bulletproof helmets market is expected to grow because of increasing demand from APAC. Technavio’s analysts forec …
- ヘリコバクター・ピロリ菌検査の世界市場2015The report presents a detailed analysis of the Helicobacter Pylori diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the H. Pylori definition, epidemiology and etiology of are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals …
- アジアの疼痛管理市場Asia-Pacific Pain Management Devices Market Outlook to 2021 Summary GlobalData’s new report, "Asia-Pacific Pain Management Devices Market Outlook to 2021", provides key market data on the Asia-Pacific Pain Management Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market. The report also provides company sha …
- 世界の酪農食品市場動向：企業M&A（2014年5月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global dairy food market during May 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global dairy food market throughout the month. Additionally, the report provides an overview of all the partne …
- バイオ肥料の世界市場The global biofertilizers market is estimated to grow at a CAGR of 14.0% for the next five years. The growth in this market is propelled by continuous growth in the organic food industry and the rising price for chemical fertilizers. The Asia-Pacific market is projected to register the highest growth by 2020 owing to the significant increase in the awareness level in consumers for health and welln …
- モバイルCDN（コンテンツデリバリネットワーク）の世界市場予測In the midst of intense competition, companies are striving for recurring businesses from existing customers. This helps them in anticipating revenue based on continuous transactions and in establishing more lucrative supplier–customer relationships. The growth in the adoption of mobile Content Delivery Network (CDN) solutions and services across various industries has created opportunities for co …
- シクロヘキサン(CX)の世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world cyclohexane market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insig …
- カプリル酸の世界市場分析：用途別（パーソナルケア、医薬品、食品･飲料）、セグメント予測The global caprylic acid market is expected to reach USD 4.4 million by 2022, according to a new report by Grand View Research, Inc. Widespread use of caprylic acid in personal care, and pharmaceutical industry coupled with the growth of these end-use industries is expected to drive growth. Furthermore, growing demand for the acid in manufacturing pesticides and surfactants is expected to propel m …
- 世界のヘルスケアにおけるIoT市場：コンポーネント別（医療機器、システム＆ソフトウェア、サービス、接続技術）、用途別（テレメディシン、コネクテッドイメージング、入院患者モニタリング）、エンドユーザー別、地域別The global Internet of Things (IoT) in healthcare market size to grow at a CAGR of 27.6% during the forecast period The IoT in healthcare market size is projected to grow from USD 55.5 billion in 2019 to USD 188.0 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 27.6% during the forecast period. The IoT in healthcare market is driven by factors, such as advancement in technology coupled …
- 沈降炭酸カルシウムの世界市場Calcium Carbonate-Precipitated (CAS 471-34-1) Market Research Report 2013 presents comprehensive data on calcium carbonate-precipitated markets globally and regionally (Europe, Asia, North America etc.) The Calcium Carbonate-Precipitated (CAS 471-34-1) Market Research Report 2013 includes calcium carbonate-precipitated description, covers its application areas and related patterns. It overviews ca …
- コンクリート流動化剤の世界市場：SNF、MLS、PC、SMFAbout concrete superplasticizers Concrete superplasticizers are admixtures formed by linear polymerization of sulfonic acids attached to polymer backbones. They play an important role in construction materials, as they enhance strength, binding properties, flowability, and workability. Concrete superplasticizers are available in two forms: powders and liquids. End-users usually prefer the liquid f …
- セノスフェアの世界市場予測（～2022年）：灰色セノスフェア、白色セノスフェア“The cenospheres market is projected to reach USD 689.2 million by 2022”The global cenospheres market was valued at USD 346.8 million in 2016 and is projected to reach USD 689.2 million by 2022, at a CAGR of 12.16% from 2017 to 2022. The growing demand from end-use industries, such as paints & coatings, refractory, construction, and oil & gas is expected to drive the market in near future. However …
- モバイル及び無線バックホール市場（世界市場予測と分析）Mobile and wireless backhaul connotates to a communication network section which facilitates transportation of mobile data traffic. With increasing Long-Term Evolution (LTE) and small-cell deployments, availability of smart communication devices, and technological progress, the telecommunication industry is foreseeing extensive growth in the mobile data traffic. Continuous need for increasing wire …
- 世界の生物活性材料及び製品（Bioactive Ingredients & Product）市場動向と予測（～2018）The market for bioactive ingredients is projected to experience a growth rate of 7.2% by 2018 to touch $33.6 billion. This estimation is attributed to the widening bioactive industry, which is a result of increased consumer awareness and health concerns. The Asia-Pacific region is the dominant market with increasing population, urbanization, and disposable income in countries such as India, China, …
